Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Skip to content
Myeloma Research News logo
  • Home
  • About Myeloma
    What Is Myeloma?
    Types
    Causes
    Symptoms
    Diagnosis
    Prognosis
  • Treatments
    Approved Treatments
    Experimental Treatments
  • News
  • What can we help you find today?

Featured News
May 2, 2022 by Vanda Pinto

Agreement Reached to Develop MMP-13 Inhibitors to Treat Myeloma

SteroTherapeutics has entered into an exclusive license agreement with Moffitt Cancer Center and Florida Atlantic University Research Corporation to develop matrix metalloproteinase 13 (MMP-13) inhibitors for treating multiple myeloma. “This partnership with Moffitt Cancer Center and…

Read more
Ukraine relief for rare disease patients | illustration of hands-in collaboration
April 29, 2022 by Hawken Miller

Organizations Rally to Help Ukrainian Rare Disease Patients

A Russian military plane crash near Tetiana Zamorska’s home in Kyiv, Ukraine, was a sign that it was time for her and her family to leave. The treacherous, 34-hour pilgrimage that ultimately brought the group of eight by car to…

Ukraine relief for rare disease patients | illustration of hands-in collaboration
April 25, 2022 by Marisa Wexler MS

Europe Awaits Proposed New Framework for Sharing Health Data

The European Commission is expected to propose a new governing framework for health data next month, called the European Health Data Space (EHDS), with the aim of connecting national health systems to facilitate secure and efficient transfer of data…

Health Insights

Check out Hypoparathyroidism News‘ collection of Health Insights, where you can find more facts and guidance

Read more

Want to know more?

Click the link below to go to our FAQs page on hypoparathyroidism.

Read more

More News

  1. MMP-13 inhibitors | Myeloma Research News | illustration of a handshake agreement
    May 2, 2022 by Vanda Pinto

    Agreement Reached to Develop MMP-13 Inhibitors to Treat Myeloma

  2. Ukraine relief for rare disease patients | illustration of hands-in collaboration
    April 29, 2022 by Hawken Miller

    Organizations Rally to Help Ukrainian Rare Disease Patients

  3. Ukraine relief for rare disease patients | illustration of hands-in collaboration
    April 25, 2022 by Marisa Wexler MS

    Europe Awaits Proposed New Framework for Sharing Health Data

  4. CD98 | Myeloma Research News | illustration of researcher
    April 18, 2022 by Marta Figueiredo

    Researchers Identify Potential Antibody-based Myeloma Therapy

  5. telehealth | illustration of doctor and patient in video appointment
    April 14, 2022 by Hawken Miller

    Telehealth Added to Latest Digital-friendly NORD State Report Card

  6. Myeloma Action Month | Myeloma Research News | illustration of woman making announcement
    April 11, 2022 by Lindsey Shapiro PhD

    Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

Swipe left to view more
View All News

Featured Health Insights

MMP-13 inhibitors | Myeloma Research News | illustration of a handshake agreement
May 2, 2022 by Vanda Pinto

Agreement Reached to Develop MMP-13 Inhibitors to Treat Myeloma

Ukraine relief for rare disease patients | illustration of hands-in collaboration
April 29, 2022 by Hawken Miller

Organizations Rally to Help Ukrainian Rare Disease Patients

Ukraine relief for rare disease patients | illustration of hands-in collaboration
April 25, 2022 by Marisa Wexler MS

Europe Awaits Proposed New Framework for Sharing Health Data

CD98 | Myeloma Research News | illustration of researcher
April 18, 2022 by Marta Figueiredo

Researchers Identify Potential Antibody-based Myeloma Therapy

telehealth | illustration of doctor and patient in video appointment
April 14, 2022 by Hawken Miller

Telehealth Added to Latest Digital-friendly NORD State Report Card

Myeloma Action Month | Myeloma Research News | illustration of woman making announcement
April 11, 2022 by Lindsey Shapiro PhD

Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

  1. MMP-13 inhibitors | Myeloma Research News | illustration of a handshake agreement
    May 2, 2022 by Vanda Pinto

    Agreement Reached to Develop MMP-13 Inhibitors to Treat Myeloma

  2. Ukraine relief for rare disease patients | illustration of hands-in collaboration
    April 29, 2022 by Hawken Miller

    Organizations Rally to Help Ukrainian Rare Disease Patients

  3. Ukraine relief for rare disease patients | illustration of hands-in collaboration
    April 25, 2022 by Marisa Wexler MS

    Europe Awaits Proposed New Framework for Sharing Health Data

  4. CD98 | Myeloma Research News | illustration of researcher
    April 18, 2022 by Marta Figueiredo

    Researchers Identify Potential Antibody-based Myeloma Therapy

  5. telehealth | illustration of doctor and patient in video appointment
    April 14, 2022 by Hawken Miller

    Telehealth Added to Latest Digital-friendly NORD State Report Card

  6. Myeloma Action Month | Myeloma Research News | illustration of woman making announcement
    April 11, 2022 by Lindsey Shapiro PhD

    Myeloma Action Month Reaches More Than 30M Worldwide, Foundation Says

Swipe left to view more
Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

BioNews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • Publishing Team
  • Leadership
  • Our Values
  • Corrections Policy
  • Careers
  • Contact Us
  • Terms of Service
  • Disable Notifications
  • Advertising Policy
  • Privacy Policy
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2022 All rights reserved.